信息搜索
信息关键字:医药
 

共有1602条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81]

·上海医药:注射用胸腺法新通过仿制药一致性评价2023-11-6 16:55:18
·医药行业周报:持续看好医药底部机会2023-11-6 16:43:18
·医药板块三报总结:资金、政策、基本面共振,上行大周期来临2023-11-6 14:57:55
·恒瑞医药卡泊芬净降价80%中标国采2023-11-6 13:24:39
·恩威医药(301331)11月3日主力资金净卖出163.95万元2023-11-6 12:32:01
·医药生物行业跟踪周报:GSK的RSV疫苗销售超预期,重点推荐智飞生物2023-11-6 11:19:10
·恒瑞医药“五折”启动新一轮员工持股计划 创新药是重要考核指标2023-11-6 1:03:56
·医药生物行业周报:医药继续领涨,多元配置医药仓位2023-11-5 18:38:49
·员工5折购!医药一哥激励计划再锁两年创新药收入 BD“功臣”在激励之列2023-11-4 11:12:43
·股票行情快报:鹭燕医药(002788)11月3日主力资金净买入248.07万元2023-11-4 4:53:59
·毕得医药:公司控股股东、实际控制人拟500万元至1000万元增持公司股份2023-11-3 23:09:24
·医药生物行业上市公司2023年三季报综述:多重底部共振,四季度或迎拐点2023-11-3 22:15:53
·医药成长50强来了!中药板块前三季度增长强劲,外资重仓26只医药股,这只疫苗龙头最被机构看好2023-11-3 10:25:44
·股票行情快报:景峰医药(000908)11月2日主力资金净卖出127.38万元2023-11-3 0:23:53
·上海医药:B019注射液获药物临床试验批准通知书2023-11-2 22:21:08
·股票行情快报:北大医药(000788)11月2日主力资金净卖出286.66万元2023-11-2 22:17:08
·以创新驱动高质量发展 深市生物医药公司前三季度实现营收8460亿元2023-11-2 21:27:24
·资源和能力互补 恩威医药重整信心药业迎来新进展2023-11-2 21:12:08
·以创新驱动高质量发展 深市生物医药公司前三季度实现营收8460亿元2023-11-2 21:06:14
·恒瑞医药:截至10月31日累计回购股份14082323股2023-11-2 16:44:37

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81]